瑞马唑仑

瑞马唑仑（CAS 308242-62-8）的公开数据库记录，列此仅供独立核对。

物理形态与操作说明

• Sparingly soluble

这个物质在各数据库里的编号

数据库记载的用途

• Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
• Remimazolam is an ultra-short acting benzodiazepine used intravenously for induction and maintenance of sedation for adults undergoing short term procedures not requiring general anesthesia. Remimazolam sedation has not been associated with serum aminotransferase elevations and has not been linked to cases of clinically apparent liver injury.
• Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Benzodiazepines; Anesthetics, Intravenous
• Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.
• Avoid alcohol. The sedative effects of benzodiazepines may be exacerbated by the co-administration of alcohol.
• N05CD - Benzodiazepine derivatives

它在各数据库里的别名

Remimazolam; 308242-62-8; CNS 7056; CNS-7056; ONO-2745; 7V4A8U16MB; ONO2745; 4H-Imidazo(1,2-a)(1,4)benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ester, (4S)-; CNS7056; remimazolamum; RefChem:57866; N05CD14; methyl 3-((4S)-8-bromo-2-methyl-6-pyridin-2-yl-4H-imidazo(1,2-a)(1,4)benzodiazepin-4-yl)propanoate; Byfavo (TN); Remimazolam [INN]; UNII-7V4A8U16MB

计算机算出的分子描述符

数据库摘要

Remimazolam · CAS 308242-62-8 · C21H19BrN4O2. UNII 7V4A8U16MB.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。